{"id":"https://openalex.org/A5000065403","orcid":"https://orcid.org/0009-0006-7206-9172","observed_orcids":["https://orcid.org/0009-0006-7206-9172"],"display_name":"Thomas Strakosch","raw_author_names":["Strakosch, Thomas","T Strakosch","Thomas Strakosch"],"full_name":"Thomas Strakosch","works_count":4,"cited_by_count":4,"summary_stats":{"2yr_mean_citedness":1.0,"h_index":1,"i10_index":0},"ids":{"openalex":"https://openalex.org/A5000065403","orcid":"https://orcid.org/0009-0006-7206-9172","observed_orcids":["https://orcid.org/0009-0006-7206-9172"]},"affiliations":[{"institution":{"id":"https://openalex.org/I4210100309","ror":"https://ror.org/0134kq024","display_name":"Cell and Gene Therapy Catapult","country_code":"GB","type":"facility","lineage":["https://openalex.org/I4210100309"]},"years":[2026]}],"last_known_institutions":[{"id":"https://openalex.org/I4210100309","ror":"https://ror.org/0134kq024","display_name":"Cell and Gene Therapy Catapult","country_code":"GB","type":"facility","lineage":["https://openalex.org/I4210100309"]}],"topics":[{"id":"https://openalex.org/T10065","display_name":"Atrial Fibrillation Management and Outcomes","count":3,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","count":3,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10227","display_name":"Acute Ischemic Stroke Management","count":2,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","count":1,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10839","display_name":"Pancreatic function and diabetes","count":1,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"topic_share":[{"id":"https://openalex.org/T10065","display_name":"Atrial Fibrillation Management and Outcomes","value":1.21e-05,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","value":7.9e-06,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11171","display_name":"Diabetes and associated disorders","value":6.5e-06,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","value":4e-06,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10227","display_name":"Acute Ischemic Stroke Management","value":3.9e-06,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"x_concepts":[{"id":"2780638905","wikidata":"https://www.wikidata.org/wiki/Q414462","display_name":"Apixaban","score":0.9815999865531921},{"id":"2778661090","wikidata":"https://www.wikidata.org/wiki/Q420262","display_name":"Rivaroxaban","score":0.9362090826034546},{"id":"71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","score":0.9192000031471252},{"id":"2779161974","wikidata":"https://www.wikidata.org/wiki/Q815819","display_name":"Atrial fibrillation","score":0.7691879272460938},{"id":"126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","score":0.5260947942733765}],"counts_by_year":[{"year":2024,"works_count":1,"oa_works_count":1,"cited_by_count":0},{"year":2025,"works_count":2,"oa_works_count":2,"cited_by_count":0},{"year":2026,"works_count":1,"oa_works_count":1,"cited_by_count":4}],"display_name_alternatives":["Strakosch, Thomas","T Strakosch","Thomas Strakosch"],"block_key":"t strakosch","works_api_url":"https://api.openalex.org/works?filter=author.id:A5000065403","awards_count":0,"updated_date":"2026-11-07T12:08:38","created_date":"2024-06-16T00:00:00"}